Type I HAE, which accounts for approximately 85% of cases, occurs due to a genetic mutation leading to a reduced quantity of secreted functional C1-INH. 1,7 In type II HAE, which occurs in ...

If healthcare professionals suspect HAE, laboratory testing is necessary to confirm the diagnosis. This usually involves a blood test to check for levels of two types of proteins found in your ...

HAE is a rare genetic disorder estimated to affect about 1 in 10,000 to 1 in 50,000 people worldwide that can result in unpredictable and potentially life-threatening recurring attacks of ...

CSL has been given approval by the European Commission for Andembry, the first once-monthly preventive therapy for the attacks that characterise rare genetic disorder hereditary angioedema (HAE).

“While there’s been notable advancement in the HAE treatment landscape, there is still an urgent need for a medicine that effectively reduces attacks, is well tolerated and simple to administe ...